The pharmaceutical industry and research in 2002 and beyond

Area of Science:

• Pharmaceutical research and development
• Biotechnology
• Drug discovery

Background:

• The pharmaceutical industry's success relies on meeting clinical needs in established markets.
• Past declines in new drug approvals may signal the end of traditional drug discovery methods.

Purpose of the Study:

• To analyze trends and predict future directions in pharmaceutical R&D.
• To identify key drivers for the anticipated rise in new drug development.

Main Methods:

• Review of R&D budgets, technological advancements, and emerging scientific fields.
• Analysis of market trends for small-molecule drugs versus protein-based therapeutics.
• Examination of research into novel targets like G-protein-coupled receptors and signal transduction pathways.

Main Results:

• Anticipated increase in the number and quality of new drugs due to R&D investment and efficiencies.
• Expansion of the market for protein products, including monoclonal antibodies and vaccines.
• Emergence of new drugs from research in areas such as G-protein-coupled receptors and cell cycle regulation.

Conclusions:

• The pharmaceutical industry is entering a new era of innovation, moving beyond traditional drug hunting.
• Technological advancements and a deeper understanding of human genetics will fuel future drug development.
• A diverse pipeline of therapeutics, including biologics and novel small molecules, is expected.